PRODUCT

°í°´¸¸Á·À» À§ÇØ Áö¼ÓÀûÀ¸·Î °í¹ÎÇϰí Çõ½ÅÇÏ¿© ÃÖ°íÀÇ Ç°ÁúÀ» Á¦°øÇÕ´Ï´Ù.

R&D reagents

Product > R&D reagents
Flavoxate HCl, 98% (HPLC)
CAS No 69869-5g
Á¦Ç°¹øÈ£ AK Sci.(USA)
Á¦Á¶»ç ¼öÀÔ»ê
Àç°í 1 EA
±Ý¾× 95,000¿ø
Æ÷Àå´ÜÀ§



3-Methyl-4-oxo-2-phenyl-4H-1-benzopyran-8-carboxylic acid 2-(1-piperidinyl)ethyl ester hydrochloride





¡Ø È­Çиí : Flavoxate HCl, 98% (HPLC)

 

¡Ø µî±Þ : APIs and Bioactives > AChR Agonists

 

¡Ø ÆÇ¸Å Æ÷Àå´ÜÀ§ : 5g , 25g

 

¡Ø È­ÇÐ½Ä : C24H26ClNO4

 

¡Ø CAS # : [3717-88-2]

 

 

IDENTITY
CAS Registry #:

 

[3717-88-2]

MDL Number: MFCD00072099
MF: C24H26ClNO4
MW: 427.92
EINECS: 223-066-4
SPECIFICATIONS & PROPERTIES
Purity: 98% (HPLC)
Available Spectra: FT-IR, LCMS, HPLC
Physical Form: White to off-white to light yellow crystals or powder
Melting Point: 247-250¡ÆC
Long-Term Storage:

 

Store at room temperature

Shipping: Not Regulated for Shipping

BIOLOGICAL INFO
Solubility: H2O: ~6.6 mg/mL
Application(s): Muscarinic antagonist
Form: HCl salt

REVIEW

Flavoxate acts as a direct antagonist at muscarinic acetylcholine receptors in cholinergically innervated organs. Its anticholinergic-parasympatholytic action reduces the tonus of smooth muscle in the bladder, effectively reducing the number of required voids, urge incontinence episodes, urge severity and improving retention, facilitating increased volume per void.

Risk Description(s)
R22: Harmful if swallowed.
R36/37/38: Irritating to eyes, respiratory system and skin

Safety Description(s)
S26: In case of contact with eyes, rinse immediately with plenty of water and seek medical advice.